Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SIBN | PRCT |
|---|---|---|
| Price | $19.10 | $17.91 |
| Change today | ▼ 2.30% | ▲ 2.28% |
| Market cap | $856.03M | $1.03B |
| Return, 3 months | +9.6% | -9.3% |
| Return, year to date | -3.1% | -43.1% |
| Return, 1 year | +25.6% | -48.5% |
| P/E (TTM) | -57.9 | -9.2 |
| P/B | 4.7 | 3.0 |
| P/E percentile vs own 5y | 1st | 91st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +15.2% | +19.3% |
| Net profit growth (YoY) | +33.6% | -37.2% |
| Gross margin | 79.5% | 64.2% |
| Operating margin | -8.3% | -33.9% |
| Net margin | -6.9% | -32.5% |
| Return on equity | -8.3% | -30.2% |
| Analyst target vs. price | +28.3% | +29.8% |
| Analyst buy share | 100% | 36% |
| RSI (14) | 54 | 43 |
| 30-day volatility | 35.1% | 55.8% |
| Max drawdown, 1 year | -45.7% | -54.9% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
